ESSA Pharma Inc. — Director's Dealing 2023

Nov 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2023-10-24

Reporting Person: Wood David S. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-24	Stock Option (Right to Buy)	$3.91	A	3750	Acquired	2033-10-24	Common Shares (3750)	Direct

Footnotes

F1: 25% of the options vest after 12 months from the date of grant. 75% vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month thereafter.